Print

Medivir AB (MVIRb.F): Interim Report, 1 January-30 September 2012*  
11/20/2012 9:54:09 AM

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir (STO:MVIR-B): Interim period, January-September 2012

Net turnover totalled SEK 399.5 million (SEK 566.8 m), of which non-recurrent payments comprised SEK 0.0 million (SEK 401.2 million), sales of pharmaceuticals, SEK 120.6 million (SEK 63.7 m), and sales via parallel imports, SEK 277.7 million (SEK 101.2 m).


//-->